Edition:
United States

Sinclair Pharma PLC (SPH.L)

SPH.L on London Stock Exchange

29.38GBp
11:12am EDT
Change (% chg)

0.12 (+0.43%)
Prev Close
29.25
Open
29.00
Day's High
29.00
Day's Low
29.00
Volume
37,069
Avg. Vol
638,554
52-wk High
36.35
52-wk Low
26.00

SPH.L

Chart for SPH.L

About

Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and... (more)

Overall

Beta: -0.09
Market Cap(Mil.): £147.35
Shares Outstanding(Mil.): 503.77
Dividend: --
Yield (%): --

Financials

  SPH.L Industry Sector
P/E (TTM): -- 31.45 32.56
EPS (TTM): -0.02 -- --
ROI: -7.20 15.33 14.89
ROE: -11.27 16.35 16.13

BRIEF-Sinclair Pharma posts HY unaudited sales 20 mln stg

* Says unaudited sales for HY were 20.0 million stg Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Jul 11 2017

BRIEF-Sinclair Pharma acquires worldwide rights to Refine Support System

* Acquired Refine Support System, an FDA cleared suture based breast-lifting technology, for total consideration of up to $11.3 mln Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Jun 19 2017

BRIEF-Alliance Pharma updates on settlement agreement with Sinclair Pharma

* Reached agreement with Sinclair Pharma for compensation in connection with material reduction of business in Kelo-Stretch™

Mar 21 2017

BRIEF-Sinclair Pharma posts FY sales growth of 51 pct

* FY sales growth of 51% at £37.8 million, (2015: £25.0 million, 18 months £45.5 million)

Mar 21 2017

Earnings vs. Estimates